AMANDA MINICH: Open Payments
NPI 1467681387 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 46 payments from 7 companies in 2025. Trend: 2023 $1,847 · 2024 $1,748 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 24 | $470 |
| ViiV Healthcare Company | 13 | $160 |
| Merck Sharp & Dohme LLC | 3 | $73 |
| Braeburn Inc. | 3 | $53 |
| SANOFI PASTEUR INC. | 1 | $24 |
| Lilly USA, LLC | 1 | $16 |
| Indivior Inc. | 1 | $14 |
Products named: PIFELTRO, CABENUVA, BRIXADI, APRETUDE, DOVATO, FLUZONE HIGH-DOSE, Yeztugo, MOUNJARO.
Industry payments across MI — which companies pay providers there.
